| Amerge® | |
| Brand Name: | Amerge® |
| Active Ingredient: | naratriptan hydrochloride |
| Strength(s): | 1 mg and 2.5 mg |
| Dosage Form(s): | Tablets |
| Company Name: | Glaxo Wellcome |
| Availability: | Prescription only |
| *Date Approved by FDA: | February 10, 1998 |
| *Approval by FDA does not mean that a new drug will be immediately marketed and available to consumers. | |
| What is Amerge used for? Amerge is used for
the short term treatment of most migraine attacks in adults. Amerge is not used to prevent
migraines,
or to decrease the number of migraine
attacks. Amerge has not been shown to treat cluster headaches.
Who should not take Amerge? You should not if you have any of following conditions:
General Precautions: If you have the following conditions your health care provider will evaluate you to decide if Amerge is right for you:
How should I take Amerge?
What are some possible side effects of Amerge? (This is NOT a complete list of side effects reported with Amerge. Your health care provider can discuss with you a more complete list of side effects.) Some signs of rare but serious side effects include:
Other side effects may include:
For more detailed information about Amerge, ask your health care provider. |
Material on this page is for
informational purposes only,
and should not be construed as medical advice.
Always consult your physician regarding medications.
Chat Status:
